Entheos Labs

United States
Panora, Iowa, United States, 02116

Company profile

Entheos Labs company profile

Entheos Labs focuses on advancing the neuroscience of psychedelic medicines to address unmet medical needs in mental health. The company is dedicated to discovering, developing, and deploying groundbreaking psychedelic compounds. Entheos Labs aims to create a pipeline of new chemical entities derived from various psychedelic materials to treat conditions such as schizophrenia, Alzheimer's disease, and traumatic brain injury. The team consists of scientific experts and business leaders committed to reshaping the future of mental health treatment.

Business identity

Contact email
[email protected]
Phone number
+1 617-651-3442
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2022-06-01, Month

Headquarters

Postal code
02116
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$3.6M
Last funding
Seed / $3.6M / 2024-10-10
Last equity funding
Seed / $3.6M
Founders
2

Founders and investors

Founders

Jerrold RosenbaumTristan Edwards